Clinical Trials Sponsored by Elios Vision, Inc.

Total 651 results

Elios Vision, Inc.

Recruiting

Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery

Open Angle Glaucoma

Spain, France, United Kingdom
Elios Vision, Inc.

Active, not recruiting

Excimer Laser Trabeculostomy Glaucoma Treatment Study (ELTGTS)

Glaucoma, Primary Open Angle

United States
Elios Vision, Inc.

Recruiting

Safety and Feasibility of the ELIOS System in POAG Patients

Glaucoma, Primary Open Angle

United States
Visco Vision Inc.

Completed

Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens

Myopia
Visco Vision Inc.

Completed

Clinical Evaluation of Two Daily Wear Silicon Hydrogel Contact Lens

Myopia
Visco Vision Inc.

Completed

Clinical Comparison of Two Daily Disposable Silicone Hydrogel Soft Contact Lens

Myopia

Taiwan
Eleos, Inc.

Completed

Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML

Acute Myelogenous Leukemia

United States
Eleos, Inc.

Withdrawn

Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course

Acute Myelogenous Leukemia
Alios Biopharma Inc.

Completed

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Simeprevir

Chronic Hepatitis C

New Zealand, Moldova, Republic of, Mauritius, United Kingdom
Alios Biopharma Inc.

Completed

A Study of ALS-008176 in Infants Hospitalized With RSV

Respiratory Syncytial Virus Infections

United States, Taiwan, Australia, Canada, United Kingdom, Colombia, France, New Zealand, Japan, South Africa, Chile, Panama, Romania, Thailand
Alios Biopharma Inc.

Completed

A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ-63623872

Influenza in Humans

United Kingdom
Alios Biopharma Inc.

Completed

A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176

Respiratory Syncytial Virus Infections

United Kingdom
Alios Biopharma Inc.

Completed

A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus

Respiratory Syncytial Virus Infections

Australia, Singapore, United States, New Zealand, Taiwan
Alios Biopharma Inc.

Completed

A Study of AL-794 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses, and the Antiviral Activity of Multiple Doses in an Influenza Challenge Study

Influenza

United Kingdom
Alios Biopharma Inc.

Completed

A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model

Respiratory Syncytial Virus Infections

United Kingdom
Visco Vision Inc.
Jens Medical Consulting Ltd.

Completed

the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens

Myopia

Taiwan
Sirion Therapeutics, Inc.
ReVision Therapeutics, Inc.

Completed

Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

Geographic Atrophy | Dry Age Related Macular Degeneration
Telios Pharma, Inc.

Recruiting

A Study Of TL-925 For The Treatment of AC

Allergic Conjunctivitis

United States
Telios Pharma, Inc.

Recruiting

A Study of TL-925 for the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Alios Biopharma Inc.

Completed

A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B

Chronic Hepatitis B

Korea, Republic of, Moldova, Republic of, New Zealand, Thailand, Ukraine
Alios Biopharma Inc.

Completed

Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers

Respiratory Syncytial Virus Infections

France
Alios Biopharma Inc.

Terminated

A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection

Hepatitis C

Belgium
Alios Biopharma Inc.

Withdrawn

A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects

Hepatitis B, Chronic
Telios Pharma, Inc.

Recruiting

A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease

Dry Eye Disease

United States
Telios Pharma, Inc.

Recruiting

Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib

Primary Myelofibrosis | Myelofibrosis | Post-PV MF | Post-ET Myelofibrosis

Spain, United States, France, Poland, Italy, Germany
Telios Pharma, Inc.

Recruiting

Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

Myelofibrosis | Indolent Systemic Mastocytosis

United States, Spain, Belgium, Australia, Taiwan, Germany, Poland, Korea, Republic of, Hungary, Brazil, Bulgaria, France, Italy
Telios Pharma, Inc.

Completed

A Study of TL-925 as a Treatment for Dry Eye Disease

Dry Eye Disease

United States
Telios Pharma, Inc.

Active, not recruiting

Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed/Refractory B Cell Malignancies | Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma | Treatment-Naive B Cell Malignancies

United States, Poland, Ukraine, Hungary, Italy, Russian Federation, United Kingdom
Telios Pharma, Inc.

Completed

A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer

COVID-19 | Carcinoma | Cancer | Solid Tumor | Sars-CoV2 | Blood Cancer

United States
Alios Biopharma Inc.

Completed

First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Chronic Hepatitis C

France, Moldova, Republic of, Georgia
Alios Biopharma Inc.

Completed

A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Participants

Hepatitis B

New Zealand
Alios Biopharma Inc.

Terminated

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healthy Volunteers

Healthy

United Kingdom
Alios Biopharma Inc.

Terminated

Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers

Hepatitis B | Chronic Hepatitis B | Viral Hepatitis B

New Zealand
Alios Biopharma Inc.

Completed

A Study to Assess the PK of AL-794 Formulations in Healthy Subjects

Influenza

United Kingdom
Notal Vision Ltd.

Completed

Retinal Imaging Using NOTAL-OCT V3.0

AMD | DR

Israel
Notal Vision Ltd.

Completed

HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device (AREDS)

Age Related Macular Degeneration

United States
Notal Vision Ltd.

Completed

Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration

United States
Notal Vision Ltd.

Completed

HMP (Home Macular Perimeter) -Usability Trial

Age Related Macular Degeneration
Notal Vision Ltd.

Completed

Sensitivity of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration | Choroidal Neovascularization

United States
Notal Vision Ltd.

Completed

Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration (CNV)

Age Related Macular Degeneration | Choroidal Neovascularization

United States
Notal Vision Ltd.

Completed

Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

Usage of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients (UU2)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

Age-Related Macular Degeneration (AMD) - Usability Study (AMD)

Age Related Macular Degeneration
Notal Vision Ltd.

Completed

Sensitivity and Specificity of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

Retinal Imaging Using NOTAL-OCT

Age-Related Macular Degeneration | Diabetic Retinopathy
Notal Vision Ltd.

Completed

Usability and Ergonomic Evaluation of Self-Positioning System for Retinal Imaging

AMD Population - Intermediate or Advanced AMD | DR Population- With or Without Diabetic Macular Edema

Israel
Notal Vision Ltd.

Withdrawn

Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)

Age Related Macular Degeneration | Choroidal Neovascularization

France
Notal Vision Ltd.

Completed

Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects

Age Related Macular Degeneration

Israel

3

Subscribe